Comprehensive HCP Access and Research Coverage Across Arthritis, Gout, Osteoporosis, and Other Key Rheumatic Conditions
Konovo’s Rheumatology Therapeutic Breakdown delivers a detailed look at global market research capabilities in rheumatic disease care. Over the past three years, we have completed more than 325 projects, delivering 18,705 respondent completes across the Americas, Europe, and Asia. Our verified panel of over 2 million healthcare professionals includes rheumatologists, nurse practitioners, physician assistants, and internal medicine specialists, providing insights into conditions such as rheumatoid arthritis, psoriatic arthritis, gout, osteoporosis, fibromyalgia, osteoarthritis, Sjögren’s syndrome, giant cell arthritis, and ankylosing spondylitis. Backed by proprietary technologies and rigorous quality controls, Konovo ensures representative, high-quality data to help pharmaceutical, biotech, and medical device companies make informed, data-driven decisions in the rheumatology therapeutic area.